Financials

  • Market Capitalization 7.47 M
  • Employee 6
  • Founded 1981
  • CEO Eric A. Adams
  • Website www.inmedpharma.com
  • Headquarter British Columbia, Canada
  • FIGI BBG000BT4589
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.5
Rapporto prezzo/fatturato
-99.06

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4739
SNGX
Soligenix, Inc. - Common Stock
0.35 USD-2.78%-2.78%-5.41%-69.03%7.62 M USD
4741
CNSP
CNS Pharmaceuticals, Inc. - Common Stock
5.19 USD-2.81%-3.17%-8.95%-42.33%7.58 M USD
4748
APRE
Aprea Therapeutics, Inc. - Common Stock
0.59 USD-1.67%-13.24%-23.38%-60.93%7.43 M USD
4752
AZTR
Azitra Inc Common Stock
0.12 USD-7.69%-14.29%-33.33%-27.10%7.27 M USD

Notizie